Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

A Bicistronic Vector Expressing CD16 and a Membrane Bound IL-15 Construct in iPSC Derived NK Cells Increased Cytotoxicity and Persistence

Alexander G Allen, Rithu Pattali, Kaitlyn M Izzo, Jared A Getgano, Kevin M Wasko, Laura C Blaha, John A Zuris, Kate Zhang, Mark S Shearman, Kai-Hsin Chang

Blood (2021) 138 (Supplement 1): 4809.

https://doi.org/10.1182/blood-2021-153258

Published: 2021

Journal Articles

Preclinical Development of EDIT301, an Autologous Cell Therapy Comprising AsCas12a-RNP Modified Mobilized Peripheral Blood-CD34 + Cells for the Potential Treatment of Transfusion Dependent Beta Thalassemia

Patricia Sousa, Tusneem Janoudi, Edouard deDreuzy, Mark S Shearman, Kate Zhang, Kai-Hsin Chang

Blood (2021) 138 (Supplement 1): 1858.

https://doi.org/10.1182/blood-2021-149956

Published: 2021

Journal Articles

Deletion of CISH and TGFβR2 in iPSC-Derived NK Cells Promotes High Cytotoxicity and Enhances In Vivo Tumor Killing

Alexandra Gerew, Steven Sexton, Kevin M Wasko, Mark S Shearman, Kate Zhang, Kai-Hsin Chang, Samia Q. Khan

Blood (2021) 138 (Supplement 1): 2780.

https://doi.org/10.1182/blood-2021-150731

Published: 2021

Journal Articles

Robust Pre-Clinical Results and Large-Scale Manufacturing Process for Edit-301: An Autologous Cell Therapy for the Potential Treatment of SCD

Edouard De Dreuzy, PhD, Jack Heath, Patricia Sousa, Tusneem Janoudi, Harry An, PhD, Scott Hansen, David K. Wood, PhD, Charles F Albright, PhD, Sandra Teixeira, PhD, Tamara Monesmith, Kate Zhang, PhD, Kai-Hsin Chang, PhD

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-140073

Published: 2020